Inventor · disambiguated record
Vincent Santora
Also filed as: SANTORA VINCENT · SANTORA VINCENT J · SANTORA VINCENT JOHN
17 granted patents·7 pending applications·315 citations·filing 2001–2025
92Inventor score
Files withAMGEN INC10DART NEUROSCIENCE CAYMAN LTD6ARENA PHARM INC2DART NEUROSCIENCE LLC2SANTORA VINCENT J2
Top patents by PatentIndex Score
24 records- 0196US6645990B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2002·Granted Nov 11, 2003·172 cites·18 claims
- 0295US7196104B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2003·Granted Mar 27, 2007·120 cites·13 claims
- 0394US11718617B2Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of useAMGEN INC·Filed 2022·Granted Aug 8, 2023·4 cites·30 claims
- 0494US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0593US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0693US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0782US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 0881US12319691B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 0981US11685745B2Substituted benzoxazole and benzofuran compounds as PDE7 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Jun 27, 2023·2 cites·32 claims
- 1077US9708334B2Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jul 18, 2017·2 cites·20 claims
- 1176US12319702B2Substituted benzoxazole and benzofuran compounds as PDE7 inhibitorsDART NEUROSCIENCE LLC·Filed 2023·Granted Jun 3, 2025·0 cites·15 claims
- 1276US9150572B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Oct 6, 2015·2 cites·3 claims
- 1376US9102674B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Aug 11, 2015·2 cites·35 claims
- 1474US2025388574A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 1572US9675605B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jun 13, 2017·1 cites·7 claims
- 1671US12252489B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 1759US9956213B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted May 1, 2018·0 cites·18 claims
- 1850US2010331312A1Modulators of the histamine h3 receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2009·Application pending·0 cites
- 1946US2010240653A1Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related theretoSANTORA VINCENT J·Filed 2007·Application pending·0 cites
- 2040US2008255137A1N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related TheretoARENA PHARM INC·Filed 2005·Application pending·0 cites
- 2139US2008119477A1N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related TheretoSMITH BRIAN M·Filed 2005·Application pending·0 cites
- 2238US2002173507A1Urea compounds and methods of usesFiled 2001·Application pending·0 cites
- 2337US2008004263A1Ligands of Follicle Stimulating Hormone Receptor and Methods of Use ThereofSANTORA VINCENT J·Filed 2005·Application pending·0 cites
- 2436US10040759B2Substituted azetidinyl compounds as GlyT1 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Aug 7, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Vincent Santora files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →